Operating Profit Cambiamento Data
AbbVie USD 3.73B 5.22B 2025-03
Adma Biologics USD 37.08M 2.56M 2024-12
Amgen USD 2.31B 182M 2024-12
AstraZeneca USD 3.67B 1.64B 2025-03
Biogen USD 441.4M 24.4M 2024-12
BioMarin Pharmaceutical USD 161.41M 47.51M 2024-12
Bristol-Myers Squibb USD 3.41B 2.62B 2025-03
Dynavax Technologies USD -1632000 11.71M 2024-12
Gilead Sciences USD 2.24B 215M 2025-03
Glaxosmithkline GBP 702M 513M 2024-12
Merck USD 5.87B 1.57B 2025-03
Neurocrine Biosciences USD 142M 41.8M 2024-12
Novartis USD 2.28B 1.34B 2024-12
Pfizer USD -409000000 5.57B 2024-12
Regeneron Pharmaceuticals USD 990.2M 189.3M 2024-12
Roche Holding CHF 4.39B 1.04B 2024-12
Sarepta Therapeutics USD 161.68M 139.48M 2024-12
TG Therapeutics USD 29.95M 17.52M 2024-12
Vertex Pharmaceuticals USD 1.03B 90.3M 2024-12



Dynavax Technologies L'Utile Operativo - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.